All News

Janet Pope Tweet
Janetbirdope
Common sense to ⬇️#rheumatoidarthritis 6S412 G Burmester summarizes decades of RA research - avoidance strategies =healthy lifestyle. ?asked is sero+RA diff than seronegative? Maybe. other Abs likely exist @RheumNow #ACR21 #ACRBest https://t.co/RT3dHDfdWp
David Liew Tweet
drdavidliew
After elegantly laying out the sophisticated science at #ACR21, Gerd Burmester finishes with this: Without waiting, 11 things we can actually do now to reduce our chance of RA @The_IMJ Ranjeny Thomas and @lynmarch1 et al @RheumNow https://t.co/Be1Jyw9FOo
Richard Conway Tweet
RichardPAConway
@AUGarren @DavidLeverenz demonstrate significant gaps in DMARD lab safety monitoring in telehealth setting. Small improvement over time but still <50% 😱 Abstr#0146 #ACR21 @RheumNow https://t.co/FDp7ZwzfO5
Janet Pope Tweet
Janetbirdope
OK am trying to learn about VEXAS ⬇️hearing, periorbital Edelman, chondritis, VTE, pulmonary infiltrates, Sweets, Arthritis. Genetic adult auto inflammatory syndrome ⬆️Men Rx steroids, then IL6i, etc. IL1i has ⬆️skin reactions 6S410 #ACR21 #gamechanger @RheumNow #ClinicalPearl https://t.co/OYRi1yAal5
Pedro Castillo Tweet
_Castillo_Pedro
Too many great points in this presentation! Making sense of the IL-23 inhibitor failure in axSpA studies. From Dr. Atul Deodhar's presentation at #ACR21 6S403 session @RheumNow https://t.co/Iv0LCNob5J
Akhil Sood MD Tweet
AkhilSoodMD
Abst 0482 Baker and colleagues showed that in patients with Type 2 DM, metformin use is associated with significantly lower risk of developing #OA and time to joint replacement #ACR21 @RheumNow https://t.co/a00g3HMrM0
Mrinalini Dey Tweet
DrMiniDey
Lots of excellent abstracts at #ACR21 on assessment & impact of #comorbidities & #multimorbidity in RA, some discussed in this article @RheumNow: https://t.co/WXgv1GmHD6 Featured abstracts: #0798 https://t.co/02BRqYp9Yk #1450 https://t.co/iG2s2Cy8Q0 #1924 https://t.co/qHws6ALENH
Janet Pope Tweet
Janetbirdope
Cool talk by P Grayson - how to design ANCA vasculitis RCTs with biomarkers, umbrella/basket RCT designs to treat pts MORE likely to respond. Also for an individual, following ANCA is not that helpful for altering Rx Take a look at this session GS401 #ACR21 #ACRBest @RheumNow https://t.co/nrapO9i4gw
Akhil Sood MD Tweet
AkhilSoodMD
Abst 0478 Binvignat et al performed hierarchical clustering analysis based on cardinal symptoms in hand OA - Identified 5 Phenotypes - Symptoms correlated with metabolic syndrome, joint destruction & physical and psychological burden #ACR21 @RheumNow https://t.co/O9hweqNIS8
Pedro Castillo Tweet
_Castillo_Pedro
Dr. Atul Deodhar with an excellent presentation on treatment in axSpA and axPsA. Note ustekinumab and risankizumab did not show improvement in axSpA. However, these studies did not include axPsA. @ACR21 6S403 @RheumNow https://t.co/F73lvpF2at
Pedro Castillo Tweet
_Castillo_Pedro
More from Dr. Atul Deodhar on treatment of axSpA and axPsA. Guselkumab studies DISCOVER 1 & 2 looked at PsA with sacroiliitis and demonstrated improved measures of axial activity, but we need more studies and to include MR imaging. #ACR21 6S403 session @RheumNow https://t.co/8jM5Fj8MuD
Olga Petryna Tweet
DrPetryna
Abst 0370 #ACR21 @rheum survey of PCPs reveals lack of awareness about inflammatory back pain: 58%never/rarely assess for IBP; 40% not comfortable with making the dx of IBP. 83%never/rarely ordered HLAB27, 65% never/ rarely ordered CRP, 72% rarely/never ordered X-ray SI joint
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×